Table 6 –

Spillover Effects on Non-Advertised Chronic Drugs

	Reduced Form				2SL
Dependent Variable: # of Prescriptions	Advertised Drugs	Non-Advertised »Drugs: Generic	Non-Advertised Drugs: Brand	Total	Advertised Drugs	Non-Advertised »Drugs: Generic	Non-Advertised Drugs: Brand	Total
	(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)
A. Instrument=Share65+ *Post
Post*Share65+	0.107***	0.100***	0.025***	0.233***
	(0.023)	(0.027)	(0.007)	(0.038)
Views per Person (Non-Elderly)					0.017***	0.016***	0.004***	0.037***
					(0.004)	(0.005)	(0.002)	(0.008)
B. Instrument=High Elderly Share * Post
High Elderly Share*Post	0.005***	0.006***	0.001	0.011***
	(0.001)	(0.002)	0.000	(0.002)
Views per Person (Non-Elderly)					0.014***	0.016***	0.002	0.032***
					(0.005)	(0.005)	(0.002)	(0.008)
Mean of Dep. Var (pre- Part D)	0.11	0.04	0.03	0.18	0.11	0.04	0.03	0.18
Zipcode x Condition x Quarter Obs	107,345	107,345	107,345	107,345	107,345	107,345	107,345	107,345

Notes:

^***p<0.01,

^**p<0.05,

^*p<0.1. Clustered standard errors at the 3-digit ZIP code level; all specifications include quarter fixed effects, 3-digit ZIP code fixed effects, condition fixed effects. Includes the 50 chronic drugs that advertised during the study period and the drugs in the same classes that did not advertise. Non-advertised drugs are separated into generic and brand products. Data is from 2004–2010.